MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/100/0.1/20.12.24 Stock

Warrant

DE000MG4D2J6

Market Closed - Börse Stuttgart 03:05:31 2024-07-16 pm EDT
0.123 EUR -1.60% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/100/0.1/20.12.24
Current month-31.67%
1 month-50.80%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 0.123 -1.60%
24-07-15 0.125 -37.50%
24-07-12 0.2 +10.50%
24-07-11 0.181 +13.12%
24-07-10 0.16 +8.11%

Delayed Quote Börse Stuttgart

Last update July 16, 2024 at 03:05 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D2J
ISINDE000MG4D2J6
Date issued 2024-05-16
Strike 100 $
Maturity 2024-12-20 (157 Days)
Parity 10 : 1
Emission price 1.56
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.58
Lowest since issue 0.122
Spread 0.02
Spread %14.39%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
52.79 USD
Average target price
79.72 USD
Spread / Average Target
+51.02%
Consensus